Your browser doesn't support javascript.
loading
Population Pharmacokinetics of Isoniazid in Chinese Tuberculosis Patients / 中国药学杂志
Chinese Pharmaceutical Journal ; (24): 2185-2191, 2017.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-858482
Responsible library: WPRO
ABSTRACT

OBJECTIVE:

To characterize the population pharmacokinetics of isoniazid in Chinese tuberculosis patients.

METHODS:

A total of 321 serum samples were obtained from 201 patients receiving oral doses of isoniazid. The effects of 16 covariates including demographics and blood tests to isoniazid's pharmacokinetics were evaluated. Data analysis was performed using non-linear mixed effects modeling (NONMEM). Prediction-corrected visual prediction check was performed for model evaluation.

RESULTS:

A two-compartment model with first-order absorption and linear elimination can well fit the isoniazid concentration-time data. A "MIXTURE" model was used to separate the subpopulation of 'subgroup A' and 'subgroup B'. Typical clearance of the two subpopulations were 82.7 and 19.3 L·h-1, respectively.

CONCLUSION:

Model validation shows the final model is reliable, which could be used for individualized treatment.

Full text: Available Health context: SDG3 - Health and Well-Being / Neglected Diseases Health problem: Target 3.3: End transmission of communicable diseases / Neglected Diseases / Tuberculosis Database: WPRIM (Western Pacific) Type of study: Prognostic study Language: Chinese Journal: Chinese Pharmaceutical Journal Year: 2017 Document type: Article
Full text: Available Health context: SDG3 - Health and Well-Being / Neglected Diseases Health problem: Target 3.3: End transmission of communicable diseases / Neglected Diseases / Tuberculosis Database: WPRIM (Western Pacific) Type of study: Prognostic study Language: Chinese Journal: Chinese Pharmaceutical Journal Year: 2017 Document type: Article
...